Huntington's Disease Genetic Variants encompass the spectrum of pathogenic changes in the HTT gene that cause Huntington's disease (HD), an autosomal dominant neurodegenerative disorder. Unlike most neurodegenerative diseases, HD has a single deterministic genetic cause—a CAG trinucleotide repeat expansion in the HTT gene. This genetic simplicity makes HD a unique model for understanding disease mechanisms and developing therapies.
Pathway / Mechanism Diagram
graph TD
A["HTT Gene: CAG Repeat Expansion"] --> B["Mutant Huntingtin (mHTT)"]
B --> C["Polyglutamine Aggregation"]
C --> D["Nuclear Inclusions"]
B --> E["Transcriptional Dysregulation"]
E --> F["BDNF Downregulation"]
F --> G["Striatal Neuron Vulnerability"]
B --> H["Mitochondrial Dysfunction"]
H --> I["Energy Deficit"]
B --> J["Impaired Autophagy"]
J --> K["Toxic Protein Accumulation"]
G --> L["Medium Spiny Neuron Death"]
I --> L
K --> L
L --> M["Chorea and Motor Symptoms"]
L --> N["Cognitive Decline"]
L --> O["Psychiatric Symptoms"]
style A fill:#ef5350,color:#e0e0e0
style L fill:#ef5350,color:#e0e0e0
style B fill:#5d4400,color:#e0e0e0
The HTT Gene
Gene Structure and Function
The HTT gene (also known as IT15 - "interesting transcript 15") is located on chromosome 4p16.3 and encodes huntingtin, a large protein of 3,144 amino acids. Huntingtin is essential for normal development and is expressed ubiquitously in the brain and peripheral tissues.
...
Huntington's Disease Genetic Variants
Overview
Huntington's Disease Genetic Variants encompass the spectrum of pathogenic changes in the HTT gene that cause Huntington's disease (HD), an autosomal dominant neurodegenerative disorder. Unlike most neurodegenerative diseases, HD has a single deterministic genetic cause—a CAG trinucleotide repeat expansion in the HTT gene. This genetic simplicity makes HD a unique model for understanding disease mechanisms and developing therapies.
Pathway / Mechanism Diagram
Mermaid diagram (expand to render)
The HTT Gene
Gene Structure and Function
The HTT gene (also known as IT15 - "interesting transcript 15") is located on chromosome 4p16.3 and encodes huntingtin, a large protein of 3,144 amino acids. Huntingtin is essential for normal development and is expressed ubiquitously in the brain and peripheral tissues.
Normal Huntingtin Function
Wild-type huntingtin plays important roles in:
Neuronal development: Essential for embryonic neurogenesis
Synaptic function: Regulates vesicle trafficking and neurotransmitter release
Transcriptional regulation: Supports neuronal survival through gene expression control
Axonal transport: Facilitates organelle and protein trafficking
Autophagy: Participates in cellular quality control mechanisms
CAG Repeat Expansions
Pathogenic Mechanism
HD is caused by an unstable CAG trinucleotide repeat expansion in the first exon of the HTT gene. This expansion leads to a mutant huntingtin protein with an elongated polyglutamine tract that forms toxic aggregates.
Repeat Length Categories
| CAG Repeats | Disease Status | Age of Onset | Clinical Implications | |-------------|----------------|--------------|----------------------| | < 27 | Normal | N/A | No disease risk | | 27-35 | Intermediate | N/A | Not disease-causing, but may expand in offspring (anticipation) | | 36-39 | Reduced penetrance | Variable | May or may not develop HD; onset often later | | 40-50 | Full penetrance | ~60 years | Will develop HD | | 51-90 | Full penetrance | ~40 years | Earlier onset, more rapid progression | | > 90 | Full penetrance | ~20 years | Juvenile HD (Westphal variant) |
Anticipation
The disease demonstrates anticipation—a phenomenon where successive generations present with earlier onset. This is primarily due to:
Paternal transmission bias: Paternal repeats are more unstable, especially during spermatogenesis
Repeat expansion: The repeat tends to increase when passed to offspring
Maternal effects: Maternal transmission is more stable but expansion can still occur
Juvenile Huntington's Disease
When onset occurs before age 20, the disease is termed "juvenile HD" or Westphal variant. Key features include:
Motor presentation: Predominant bradykinesia and rigidity (rather than chorea)
Seizures: Occur in approximately 30% of cases
Rapid progression: More aggressive disease course
Repeat length: Usually associated with > 60 CAG repeats
Modifier Genes
While HTT is the causative gene, several genetic modifiers influence age of onset and disease progression:
DNA Repair Genes
Variants in DNA repair genes can significantly modify the disease phenotype:
MSH3: Somatic expansion modifier; variants affect rate of repeat expansion in tissues
MUTYH: Base excision repair gene; variants influence onset age
POLD2: DNA polymerase delta; impacts repeat stability
LIG1: DNA ligase I; recent studies show variants can suppress CAG repeat expansion
[Unknown, The Huntington's Disease Collaborative Research Project. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72(6):971-983 (1993)](https://pubmed.ncbi.nlm.nih.gov/7684686/)
[MacDonald ME, et al., A novel gene containing a trinucleotide repeat that is unstable on Huntington's disease chromosome 14q11.2a. Nat Genet. 1993;4(3):327-332 (1993)](https://pubmed.ncbi.nlm.nih.gov/8458085/)
[Unknown, Gusella JF, MacDonald ME. Huntington's disease: nearly four decades of human molecular genetics. Hum Mol Genet. 2009;18(R2):R108-R114 (2009)](https://pubmed.ncbi.nlm.nih.gov/19808796/)
[Tabrizi SJ, et al., Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol. 2020;16(10):529-546 (2020)](https://pubmed.ncbi.nlm.nih.gov/32796979/)